"Lower Priced Drugs Act" To Improve Patient Access To Generic Medicines
"This bipartisan legislation will close some existing loopholes that are delaying consumers' ability to access safe, effective and affordable generic medicines. Closing these loopholes will save our healthcare system billions of dollars and bring needed, affordable care to patients sooner," said GPhA President and CEO Kathleen Jaeger.
Specifically, the legislation would improve access to generic antibiotics, streamline the citizen petition process, prevent legal delays in the generic drug approval process, and bring meaningful reform to the pediatric exclusivity period.
"With generics costing 30% to 80% less than brands, increasing access to generic medicines will strengthen access to quality, affordable care. For every one percent increase in the use of generics, consumers could save $4 billion annually. By closing loopholes, this legislation will increase access while lowering patient healthcare costs," Jaeger noted.
"We applaud Senators Stabenow and Lott for their commitment to improving consumers' access to affordable generic medicines. We look forward to working with them on passage of this important legislation," said Jaeger.
GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 63% of the total prescriptions dispensed in the United States, but less than 20% of all dollars spent on prescription drugs. For more information about the industry, visit http://www.gphaonline.org.
"Preþ mai mic act de droguri" pacientului de a îmbunãtãþi accesul la medicamente generice - "Lower Priced Drugs Act" To Improve Patient Access To Generic Medicines - articole medicale engleza - startsanatate